OptoWave focuses on improving hearing rehabilitation for patients with severe to profound hearing loss through the use of optical cochlear implants (CIs).
Current CIs employ electrical stimulation, which often leads to broad neural activation, negatively impacting speech understanding in challenging acoustic environments.
The proposed solution is an implantable device that uses focused light to directly stimulate the auditory nerve, bypassing dysfunctional hair cells.
This is achieved through a combination of micro-scale light emitters and optogenetic control via light-gated ion channels, potentially enhancing patients' quality of life significantly.
OptoWave suggests using red light-emitting waveguides coupled with laser diodes, housed in a hermetically sealed package outside the inner ear.
This approach offers advantages in terms of implant longevity and reduces reliance on corrosive materials. Additionally, red light allows for deeper tissue penetration, which may lead to improved stimulation.
Overall, the research aims to significantly enhance hearing restoration and address a critical clinical need.